GPX4 and neoplasm: We found that peritumoral siRNA‐mediated UBQLN1 knockdown significantly attenuated tumor growth (Figure 7A,B), with western blot confirmation of successful UBQLN1 reduction and concomitant GPX4 downregulation (Figure 7C).